Catalyst
Slingshot members are tracking this event:
TG Therapeutics plans to present top-line overall response rate results from their UNITY-CLL Phase 3 trial in both front line and relapsed or refractory CLL in 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TGTX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 25, 2018
Occurred Source:
http://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-announces-update-regarding-unity-cll-phase-3
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Tg-1101, Tgr-1202, Chronic Lymphocytic Leukemia, Non-hodgkin’s Lymphoma, Nhl, Unity-cll, Phase 3 Topline Data
